Max Bayer | Pharma Reporter
Endpoints News

Max Bayer is a senior reporter for Endpoints News, where he covers drugmakers' relationship with Washington and the White House. From drug pricing to FDA upheaval, Max regularly breaks news on significant policy and personnel changes impacting the biopharma industry. He previously worked at Fierce Biotech, reporting on startups and new drug development, and at CBS News, covering the twists and turns of the COVID-19 pandemic. A Bay Area native, Max spends his spare time rooting on northern California sports teams and taking his rec soccer league too seriously.